CREDO DIAGNOSTICS BIOMEDICAL PTE. LTD.

Company Snapshot

Founded: 2011
Entity Type: Private
Region: Singapore
Headquarter: Valley Point, Singapore
Key Geographics: Singapore
Corporate Address: 491B River Valley Road, #06-01, Valley Point 248373 Singapore Tel. +1- www.credodxbiomed.com

Company Overview

Based in Singapore, Credo Diagnostics Biomedical stands as a pioneering company in the field of diagnostic technologies. The company develops, produces and markets molecular diagnostic platforms that are accurate and rapid, as well as accessible and affordable at the point of care. Credo Diagnostics places a strong emphasis on delivering solutions that uphold exceptional levels of precision while simultaneously minimizing costs.

CREDO DIAGNOSTICS BIOMEDICAL PTE. LTD. In Reports

Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics

BCC Research Market Analyst says global market for polymerase chain reaction for point-of-care diagnostics is expected to grow from $1.6 billion in 2024 to $2.1 billion by the end of 2029 at a CAGR of 5.9%.

Company's Business Segments

  • Molecular Diagnostic : This segment includes Developing, Manufacturing, Commercializes Innovative, Cost-effective, Rapid Molecular Diagnostic solutions at the Point-of-Care (POC) in the areas of Human Infectious Diseases, Animal Health.

Applications/End User Industries

  • Molecular Diagnostics
  • Biomedical
  • Medical Devices
  • In-Vitro Diagnostics
  • POC Molecular Diagnostics
  • Veterinary Clinical Management
  • Medical Equipment Manufacturing
  • Near Patient Testing
  • Point-of-care Testing
AI Sentiment